ALB and neoplasm: Because albumin conjugation has been shown to extend the half-life of the IFNβ (figure 2), we explored whether a single s.c. administration of Alb-IFNβ with E7 peptide in tumor-bearing mice can elicit E7-specific CD8 +T cell-mediated immune responses and enhanced DC activity.